Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2010

01-07-2010 | Article

Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets

Authors: C. P. F. Carvalho, H. C. L. Barbosa, A. Britan, J. C. R. Santos-Silva, A. C. Boschero, P. Meda, C. B. Collares-Buzato

Published in: Diabetologia | Issue 7/2010

Login to get access

Abstract

Aims/hypothesis

Cell–cell coupling mediated by gap junctions formed from connexin (CX) contributes to the control of insulin secretion in the endocrine pancreas. We investigated the cellular production and localisation of CX36 and CX43, and gap junction-mediated beta cell coupling in pancreatic islets from rats of different ages, displaying different degrees of maturation of insulin secretion.

Methods

The presence and distribution of islet connexins were assessed by immunoblotting and immunofluorescence. The expression of connexin genes was evaluated by RT-PCR and quantitative real-time PCR. The ultrastructure of gap junctions and the function of connexin channels were assessed by freeze–fracture electron microscopy and tracer microinjection, respectively.

Results

Young and adult beta cells, which respond to glucose, expressed significantly higher levels of Cx36 (also known as Gjd2) than fetal and newborn beta cells, which respond poorly to the sugar. Accordingly, adult beta cells also showed a significantly higher membrane density of gap junctions and greater intercellular exchange of ethidium bromide than newborn beta cells. Cx43 (also known as Gja1) was not expressed by beta cells, but was located in various cell types at the periphery of fetal and newborn islets.

Conclusions/interpretation

These findings show that the pattern of connexins, gap junction membrane density and coupling changes in islets during the functional maturation of beta cells.
Appendix
Available only for authorised users
Literature
1.
Boschero AC, Tombaccini D, Atwater I (1988) Effects of glucose on insulin release and 86Rb permeability in cultured neonatal and adult rat islets. FEBS Lett 236:375–379CrossRefPubMed
2.
Boschero AC, Crepaldi SC, Carneiro EM, Delattre E, Atwater I (1993) Prolactin induces maturation of glucose sensing mechanisms in cultured neonatal rat islets. Endocrinology 133:515–520CrossRefPubMed
3.
Carvalho CPF, Martins JCR, Cunha DA, Boschero AC, Collares-Buzato CB (2006) Histomorphology and ultrastructure of pancreatic islets during in vivo maturation of rat pancreas. Ann Anat 188:221–234CrossRefPubMed
4.
Weinhaus AJ, Poronnik P, Cook DI, Tuch BE (1995) Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal rat beta-cell. Diabetes 44:118–124CrossRefPubMed
5.
Weinhaus AJ, Tabiin MT, Poronnik P, Palma CA, Cook DI, Tuch BE (2003) Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal human and porcine beta-cell. J Clin Endocrinol Metab 88:2753–2759CrossRefPubMed
6.
Mendonça AC, Carneiro EM, Bosqueiro JR, Crepaldi-Alves SC, Boschero AC (1998) Development of the insulin secretion mechanism in fetal and neonatal rat pancreatic beta cells: response to glucose, K+, theophylline, and carbamylcholine. Braz J Med Biol Res 31:841–846CrossRefPubMed
7.
Rozzo A, Meneghel-Rozzo T, Delakorda SL, Yang SB, Rupnik M (2009) Exocytosis of insulin: in vivo maturation of mouse endocrine pancreas. Ann N Y Acad Sci 1152:53–62CrossRefPubMed
8.
Navarro-Tableros V, Fiordelisio T, Hernández-Cruz A, Hiriart M (2007) Physiological development of insulin secretion, calcium channels, and GLUT2 expression of pancreatic rat β-cells. Am J Physiol Endocrinol Metab 292:E1018–E1029CrossRefPubMed
9.
Leite AR, Carvalho CPF, Furtado AG, Barbosa HCL, Boschero AC, Collares-Buzato CB (2005) Co-expression and regulation of connexins 36 and 43 in cultured neonatal rat pancreatic islets. Can J Physiol Pharm 83:142–151CrossRef
10.
Amaral ME, Ueno M, Carvalheira JB et al (2003) Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with insulin-signaling pathway. Horm Metab Res 35:282–289CrossRefPubMed
11.
Nielsen JH, Linde S, Welinder BS, Billestrup MOD (1989) Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol Endocrinol 3:165–173CrossRefPubMed
12.
Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH (1982) The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 111:86–94CrossRefPubMed
13.
Bosco D, Orci L, Meda P (1989) Homologous but not heterologous contact increases the insulin secretion of individual pancreatic B cells. Exp Cell Biol 184:72–80
14.
Meda P, Chanson M, Pepper MS et al (1991) In vivo modulation of connexin 43 gene expression and junctional coupling of pancreatic beta cells. Exp Cell Res 192:469–480CrossRefPubMed
15.
Meda P, Bosco D, Chanson M et al (1990) Rapid and reversible secretion changes during uncoupling of rat insulin-producing cells. J Clin Invest 86:759–768CrossRefPubMed
16.
Meda P, Perrelet A, Orci L (1979) Increase of gap junctions between pancreatic beta cells during stimulation of insulin secretion. J Cell Biol 82:441–448CrossRefPubMed
17.
Ravier MA, Güldenagel M, Charollais A et al (2005) Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 54:1798–1807CrossRefPubMed
18.
Wellershaus K, Degen J, Deuchars J et al (2008) A new conditional mouse mutant reveals specific expression and functions of connexin36 in neurons and pancreatic beta-cells. Exp Cell Res 314:997–1012CrossRefPubMed
19.
Calabrese A, Zang M, Serre-Beinier V et al (2003) Connexin 36 controls sychronization of Ca2+ oscillations and insulin secretion in MIN6 cells. Diabetes 52:417–424CrossRefPubMed
20.
Le Gurun S, Martin D, Formenton A et al (2003) Connexin-36 contributes to control function of insulin-producing cells. J Biol Chem 278:37690–37697CrossRefPubMed
21.
Meda P, Denef JF, Perrelet A, Orci L (1980) Nonrandom distribution of gap junctions between pancreatic beta-cells. Am J Physiol 238:C114–C119PubMed
22.
Charpantier E, Cancela J, Meda P (2007) Beta cells preferentially exchange cationic molecules via connexin 36 gap junction channels. Diabetologia 50:2332–2341CrossRefPubMed
23.
Tan C, Tuch BE, Tu J, Brown SA (2002) Role of NADH shuttles in glucose-induced insulin secretion from fetal β-cells. Diabetes 51:2989–2996CrossRefPubMed
24.
Hole RL, Pian-Smith MCM, Sharp GWG (1988) Development of the biphasic response to glucose in fetal and neonatal rat pancreas. Am J Physiol 254:E167–E174PubMed
25.
Fletcher DJ, Ways DK (1991) Age-dependent expression of protein kinase C isoforms in rat islets. Diabetes 40:1496–1503CrossRefPubMed
26.
Rutter GA (2001) Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med 22:247–284CrossRefPubMed
27.
Klee P, Bavamian S, Charollais A et al (2008) Gap junctions and insulin secretion. In: Seino S, Bell GI (eds) Pancreatic beta cell in health and disease. Springer, Tokyo, pp 114–132
28.
Theis M, Mas C, Döring B et al (2004) Replacement by a lacZ reporter gene assigns mouse connexin36, 45 and 43 to distinct cell types in pancreatic islets. Exp Cell Res 29:18–29CrossRef
29.
Serre-Beinier V, Bosco D, Zulianello L et al (2009) Cx36 makes channels coupling human pancreatic beta cells and correlates with insulin expression. Hum Mol Genet 18:428–439CrossRefPubMed
30.
Allagnat F, Klee P, Peyrou M et al (2007) The gap junctional protein Connexin36 (Cx36) protects pancreatic beta cells against cytotoxic attacks: a possible role in cytokine-mediated beta cell death. Diabetologia 50(Suppl 1):S45
31.
Jonkers FC, Jonas JC, Gilon P, Henquin JC (1999) Influence of cell number on the characteristics and synchrony of Ca+2 oscillations in clusters of mouse pancreatic islet cells. J Physiol 520:839–849CrossRefPubMed
32.
Moreno AP, Berthoud VM, Pérez-Palacios G, Pérez-Armendariz EM (2005) Biophysical evidence that connexin-36 forms functional gap junction channels between pancreatic mouse beta-cells. Am J Physiol Endocrinol Metab 288:E948–E956CrossRefPubMed
33.
Salomon D, Meda P (1986) Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp Cell Res 162:507–520CrossRefPubMed
34.
Konstantinova I, Nikolova G, Ohara-Imaizumi M et al (2007) EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 129:359–370CrossRefPubMed
35.
Meda P, Pepper MS, Traub O et al (1993) Differential expression of gap junction connexins in endocrine and exocrine glands. Endocrinology 133:2371–2378CrossRefPubMed
36.
Pérez-Armendariz M, Roy C, Spray DC, Bennett MV (1991) Biophysical properties of gap junctions between freshly dispersed pairs of mouse pancreatic beta cells. Biophys J 59:76–92CrossRefPubMed
37.
Vozzi C, Ullrich S, Charollais A, Philippe J, Orci L, Meda P (1995) Adequate connexin-mediated coupling is required for proper insulin production. J Cell Biol 131:1561–1572CrossRefPubMed
38.
Martinez AD, Hayrapetyan V, Moreno AP, Beyer EC (2002) Connexin43 and connexin45 form heteromeric gap junction channels in which individual components determine permeability and regulation. Circ Res 90:1100–1107CrossRefPubMed
39.
Bouwens L, Wang R-N, de Blay E, Pipeleers AG, Klöppel G (1994) Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes 43:1279–1283CrossRefPubMed
40.
41.
Di Bella A, Regoli M, Nicoletti C, Ermini L, Fonzi L, Bertelli E (2009) An appraisal of intermediate filament expression in adult and developing pancreas: vimentin is expressed in alpha cells of rat and mouse embryos. J Histochem Cytochem 57:577–586CrossRefPubMed
42.
Dahl E, Winterhager E, Reuss B, Traub O, Butterweck A, Willecke K (1996) Expression of the gap junction proteins connexin31 and connexin43 correlates with communication compartments in extraembryonic tissues and in the gastrulating mouse embryo, respectively. J Cell Sci 109:191–197PubMed
43.
Todorova MG, Soria B, Quesada I (2008) Gap junctional intercellular communication is required to maintain embryonic stem cells in a non-differentiated and proliferative state. J Cell Physiol 214:354–362CrossRefPubMed
44.
Duval N, Gomès D, Calaora V, Calabrese A, Meda P, Bruzzone R (2002) Cell coupling and Cx43 expression in embryonic mouse neural progenitor cells. J Cell Sci 115:3241–3251PubMed
45.
Santana A, Enseñat-Waser R, Arribas MI, Reig JA, Roche E (2006) Insulin-producing cells derived from stem cells: recent progress and future directions. J Cell Mol Med 10:866–883CrossRefPubMed
46.
Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG (2000) Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell 100:645–654CrossRefPubMed
47.
Rocheleau JV, Remedi MS, Granada B et al (2006) Critical role of gap junction coupled KATP channel activity for regulated insulin secretion. PLoS Biol 4:221–227CrossRef
Metadata
Title
Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets
Authors
C. P. F. Carvalho
H. C. L. Barbosa
A. Britan
J. C. R. Santos-Silva
A. C. Boschero
P. Meda
C. B. Collares-Buzato
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1726-8

Other articles of this Issue 7/2010

Diabetologia 7/2010 Go to the issue

For Debate

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Article

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

Article

Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study

Article

Association of glucose metabolism with diastolic function along the diabetic continuum

Article

Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice

Article

Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits